Clinical Evaluation of Ketorolac Tromethamine 0.5% Ophthalmic Solution for the Treatment of Seasonal Allergic Conjunctivitis. https://pubmed.ncbi.nlm.nih.gov/8236005/. Date Accessed October 7, 2026.
Double-Masked, Paired-Comparison Clinical Study of Ketorolac Tromethamine 0.5% Ophthalmic Solution Compared With Placebo Eyedrops in the Treatment of Seasonal Allergic Conjunctivitis. https://pubmed.ncbi.nlm.nih.gov/8236004/. Date Accessed October 7, 2026.
Efficacy and Safety of Ketorolac Tromethamine 0.5% and Levocabastine 0.05%: A Multicenter Comparison in Patients With Seasonal Allergic Conjunctivitis. https://pubmed.ncbi.nlm.nih.gov/11010060/. Date Accessed October 7, 2026.
Ketorolac Ophthalmic: MedlinePlus Drug Information. https://medlineplus.gov/druginfo/meds/a601241.html. Date Accessed October 7, 2026.
Ketorolac Tromethamine Ophthalmic Solution 0.5% Prescribing Information. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9a186ba-74a9-b6d4-1109-1e045ba1763e. Date Accessed October 7, 2026.